These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37295474)

  • 81. CoronaVac/Sinovac COVID-19 Vaccine-Related Hypersensitivity Reactions and Second-Dose Vaccine Administration: Tertiary Allergy Center Experience.
    Gumusburun R; Dalgıc CT; Mete Gokmen EN; Sin AZ
    Int Arch Allergy Immunol; 2022; 183(7):778-784. PubMed ID: 35462361
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Excipients as Potential Agents of Anaphylaxis in Vaccines: Analyzing the Formulations of Currently Authorized COVID-19 Vaccines.
    Caballero ML; Quirce S
    J Investig Allergol Clin Immunol; 2021 Feb; 31(1):92-93. PubMed ID: 33433387
    [No Abstract]   [Full Text] [Related]  

  • 83. Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine.
    Yacoub MR; Cucca V; Asperti C; Ramirez GA; Della-Torre E; Moro M; Zandalasini C; Di Napoli D; Ambrosio A; Signorelli C; Colombo S; Beretta L; Ciceri F; Zangrillo A; Dagna L
    Vaccine; 2021 Oct; 39(44):6464-6469. PubMed ID: 34598820
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Evaluation of Allergic Reactions following COVID - 19 Vaccination in Patients with Documented Allergies.
    Shukla SC; Pandit S; Soni D; Gogtay NJ
    J Assoc Physicians India; 2021 Oct; 69(10):11-12. PubMed ID: 34781647
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Reporting of Allergic Reactions During Pfizer-BioNTech BNTT162B2 Vaccination in Israel.
    Anis E; Preis SA; Cedar N; Tal Y; Hershkowitz I; Hershko AY
    J Allergy Clin Immunol Pract; 2022 Nov; 10(11):2969-2976. PubMed ID: 35872216
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Monitored COVID-19 mRNA vaccine second doses for people with adverse reactions after the first dose.
    Gallagher MC; Haessler S; Pecoy-Whitcomb E; Bayuk J
    Allergy Asthma Proc; 2022 Jan; 43(1):37-39. PubMed ID: 34983708
    [No Abstract]   [Full Text] [Related]  

  • 87. Adverse reactions to COVID-19 vaccines: A practical approach.
    Rutkowski K; Mirakian R; Till S; Rutkowski R; Wagner A
    Clin Exp Allergy; 2021 Jun; 51(6):770-777. PubMed ID: 33813758
    [TBL] [Abstract][Full Text] [Related]  

  • 88. A practical guide to address reactions to vaccines in children.
    Arcolaci A; Scarmozzino R; Zanoni G
    Pediatr Allergy Immunol; 2023 Jun; 34(6):e13967. PubMed ID: 37366202
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Anaphylaxis caused by vaccines].
    Perea-Valle P; Delgado-Aguirre CJ; Villafuerte-Domínguez BG; Del Río-Navarro BE
    Rev Alerg Mex; 2022; 69 Suppl 1():s1-s14. PubMed ID: 34998305
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Clinical Phenotypes of Immediate First-Dose Reactions to mRNA COVID-19: A Multicenter Latent Class Analysis.
    Stone CA; Robinson LB; Li L; Krantz MS; Kwah JH; Ortega G; Mancini C; Wolfson AR; Saff RR; Samarakoon U; Hong DI; Koo G; Chow TG; Gruchalla R; Liao JX; Kuster JK; Price C; Ahola C; Khan DA; Phillips EJ; Banerji A; Blumenthal KG
    J Allergy Clin Immunol Pract; 2023 Feb; 11(2):458-465.e1. PubMed ID: 36108922
    [TBL] [Abstract][Full Text] [Related]  

  • 91. COVID-19 Vaccine Anaphylaxis: Current Evidence and Future Approaches.
    Laisuan W
    Front Allergy; 2021; 2():801322. PubMed ID: 35387045
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Vaccine hesitancy in patients presenting to a specialized allergy center: clinical relevant sensitizations, impact on mental health and vaccination rates.
    Kogseder N; Puxkandl V; Hoetzenecker W; Altrichter S
    Front Immunol; 2024; 15():1324987. PubMed ID: 38827735
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Insights from American College of Allergy, Asthma, and Immunology COVID-19 Vaccine Task Force: Allergic Reactions to mRNA SARS-CoV-2 Vaccines.
    Murphy KR; Patel NC; Ein D; Hudelson M; Kodoth S; Marshall GD; Parikh P; Blaiss MS
    Ann Allergy Asthma Immunol; 2021 Apr; 126(4):319-320. PubMed ID: 33493641
    [No Abstract]   [Full Text] [Related]  

  • 94. [Allergy to Pfizer-BioNTech® vaccine demonstrated by skin testing].
    Estrada-García CD; Macías-Robles AP; Cortés-Grimaldo RM; Carvajal-Alonso HL; Barreto-Alcalá M; Ramírez-Nepomuceno A; Esparza-Amaya D; Coronado-Hernández KG; Barrios-Díaz B; Campos-Téllez HH
    Rev Alerg Mex; 2023 Jan; 69(2):89-92. PubMed ID: 36928249
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Hypersensitivity reactions to anti-SARS-CoV-2 vaccines: Basophil reactivity to excipients.
    Pignatti P; Ramirez GA; Russo M; Marraccini P; Nannipieri S; Asperti C; Torre FD; Tiri A; Gatti BM; Gurrado A; Meriggi A; Benanti G; Cilona MB; Pigatto P; Burastero SE; Dagna L; Yacoub MR
    Vaccine; 2023 Jul; 41(32):4693-4699. PubMed ID: 37349223
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The conundrum of COVID-19 mRNA vaccine-induced anaphylaxis.
    Khalid MB; Frischmeyer-Guerrerio PA
    J Allergy Clin Immunol Glob; 2023 Feb; 2(1):1-13. PubMed ID: 36532656
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Practical handling of allergic reactions to COVID-19 vaccines: A position paper from German and Austrian Allergy Societies AeDA, DGAKI, GPA and ÖGAI.
    Klimek L; Bergmann KC; Brehler R; Pfützner W; Zuberbier T; Hartmann K; Jakob T; Novak N; Ring J; Merk H; Hamelmann E; Ankermann T; Schmidt S; Untersmayr E; Hötzenecker W; Jensen-Jarolim E; Brockow K; Mahler V; Worm M
    Allergo J Int; 2021; 30(3):79-95. PubMed ID: 33898162
    [TBL] [Abstract][Full Text] [Related]  

  • 98. COVID-19 Vaccines in Children with Cow's Milk and Food Allergies.
    Liotti L; Bianchi A; Bottau P; Caimmi S; Crisafulli G; Franceschini F; Mori F; Paglialunga C; Saretta F; Caffarelli C
    Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444795
    [TBL] [Abstract][Full Text] [Related]  

  • 99. A Cost-Effectiveness Evaluation of Hospitalizations, Fatalities, and Economic Outcomes Associated with Universal Versus Anaphylaxis Risk-Stratified COVID-19 Vaccination Strategies.
    Shaker M; Abrams EM; Greenhawt M
    J Allergy Clin Immunol Pract; 2021 Jul; 9(7):2658-2668.e3. PubMed ID: 33711496
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Second-dose mRNA COVID-19 vaccine safety in patients with immediate reactions after the first dose: A case series.
    Iaboni A; Jindal N; Betschel SD; Song C
    J Allergy Clin Immunol Glob; 2022 Aug; 1(3):172-174. PubMed ID: 36203478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.